The Rising Incidences Of Seasonal Influenza Drive Growth In The Influenza Vaccine Market Is Supporting Development Across The Influenza Vaccines Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Forecasted Rise In Market Size Of The Influenza Vaccines Market During The Forecast Period?

The influenza vaccines market has seen strong growth over recent years. It is anticipated to increase from $9.04 billion in 2025 to $9.71 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.4%. This historical expansion can be ascribed to the rising prevalence of seasonal influenza, limited public awareness in early 2000s, predominance of trivalent vaccines, low global manufacturing capacity, and reliance on traditional egg-based production methods.

The influenza vaccines market size is anticipated to experience robust expansion in the near future. It is set to increase to $13.13 billion in 2030, achieving a compound annual growth rate (CAGR) of 7.8%. This growth over the forecast period can be attributed to the rising acceptance of quadrivalent vaccines, the widening application of precision medicine techniques, increasing government-led vaccination campaigns, the evolution of cell-based and recombinant vaccines, and improved cold chain and distribution systems. Significant trends expected during this period include optimizing seasonal vaccine formulations, extending pediatric immunization initiatives, a surge in government-funded flu vaccination programs, the incorporation of novel adjuvants for improved immunogenicity, and an increase in home-based and outpatient vaccine delivery methods.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp

Which Core Factors Are Supporting The Expansion Of The Influenza Vaccines Market?

The increasing occurrence of seasonal influenza is anticipated to fuel the expansion of the influenza vaccine market moving ahead. Seasonal influenza is defined as a respiratory sickness brought on by influenza viruses that commonly spread and lead to infections during particular periods annually, typically in colder seasons. This progression stems from factors such as antigenic drift, population vulnerability, environmental elements, insufficient vaccine coverage, and the absence of widespread vaccination. Influenza vaccines contribute to diminishing the instances of seasonal influenza by offering immunity against the currently circulating viral strains. For instance, in November 2023, the Centers for Disease Control and Prevention (CDC), a US-based governmental body, disclosed that the 2022-2023 flu season saw roughly 31 million flu-associated illnesses, 14 million flu-related medical appointments, 360,000 flu-associated hospital admissions, and 21,000 flu-related fatalities. Consequently, the escalating occurrences of seasonal influenza are propelling the growth of the influenza vaccines market.

What Are The Major Segment Categories Within The Influenza Vaccines Market?

The influenza vaccines market covered in this report is segmented –

1) By Vaccine Type: Inactivated, Live Attenuated

2) By Valency: Quadrivalent, Trivalent

3) By Route Of Administration: Injection, Nasal Spray

4) By Age Group: Pediatric, Adult

5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels

Subsegments:

1) By Inactivated: Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)

2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)

What Trends Are Shaping The Influenza Vaccines Market Structure?

Leading companies operating in the influenza vaccine market are implementing advanced product innovations, such as quadrivalent seasonal influenza vaccines, to enhance their respiratory vaccine offerings and financial standing. A quadrivalent seasonal influenza vaccine is formulated to protect against four different flu viruses, including two influenza A viruses and two influenza B viruses. For instance, in September 2023, Clover Biopharmaceuticals Ltd., a China-based biotechnology company, launched AdimFlu-S (QIS), a quadrivalent seasonal influenza vaccine. This vaccine is notably the only imported quadrivalent seasonal influenza vaccine approved for use in individuals aged three years and older in China. The vaccine’s quadrivalent composition improves its capability to achieve high vaccine effectiveness, regardless of which influenza B strain becomes seasonally prevalent, especially when compared to trivalent options.

Who Are The Companies Shaping The Influenza Vaccines Market Landscape?

Major companies operating in the influenza vaccines market are Pfizer Inc., Merck & Co Inc., Sanofi-Aventis LLC, GlaxoSmithKline plc, Serum Institute of India Private Limited, Seqirus Inc., CSL Limited, Daiichi Sankyo Company Limited, Moderna Inc., Novavax AB, Bharat Biotech International Limited, Valneva SE, Shionogi & Co Ltd., Sinovac Biotech Co Ltd., Walvax Biotechnology Co Ltd., Hualan Biological Engineering Inc., China National Pharmaceutical Group Corporation, Green Cross Corporation, Mitsubishi Tanabe Pharma Corporation, Osivax, Vaxess Technologies Inc., Gamma Vaccines Pty Ltd

Access The Complete Influenza Vaccines Market Report:

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

Which Region Holds The Largest Share In The Influenza Vaccines Market?

North America was the largest region in the influenza vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Influenza Vaccines Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp

Browse Through More Reports Similar to the Global Influenza Vaccines Market 2026, By The Business Research Company

Influenza Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

Influenza Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/influenza-treatment-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795